This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Pronas Pharma Ab. Active years: 2012.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2012
Title: Saema Ansar: Innovator in Ischemic Disease Treatment
Introduction
Saema Ansar is a notable inventor based in Staffanstorp, Sweden. She has made significant contributions to the field of medicine, particularly in the treatment of ischemic disorders. Her innovative approach has led to the development of a unique patent that addresses critical health issues.
Latest Patents
Saema Ansar holds 1 patent related to ischemic disorder or disease inhibitors. The invention focuses on the use of at least one inhibitor selected from the group consisting of raf-, protein kinase C (PKC)-, MEK1/2-, or ERK1/2-inhibitors. This invention is intended for the manufacturing of a medicament to be administered from 1 up to 12 hours after the initiation of an ischemic disease.
Career Highlights
Saema Ansar is currently employed at Pronas Pharma AB, where she continues to work on innovative solutions in the pharmaceutical industry. Her dedication to research and development has positioned her as a key player in her field.
Collaborations
Saema collaborates with Lars Edvinsson, contributing to the advancement of medical research and innovation.
Conclusion
Saema Ansar's work in developing inhibitors for ischemic diseases showcases her commitment to improving healthcare through innovation. Her contributions are paving the way for new treatments that can significantly impact patient outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile